Page URL: https://www.bionews.org.uk/page_90157

Stem cells rescue vision in rat model of macular degeneration

25 September 2006
Appeared in BioNews 377

Scientists from Advanced Cell Technology (ACT) working in collaboration with eye specialists from the University of Utah, have used human embryonic stem cells (ES cells) to partly restore vision in rats suffering from a form of degenerative blindness used to mimic macular degeneration. According to Robert Lanza of ACT who led the study, macular degeneration affects more than 30 million people worldwide and is the leading cause of blindness in people over 60 in the United States. The rats used in the study have been genetically altered to have defective eyes which deteriorate after birth.

The team generated a number of human ES cell lines that resembled retinal pigment epithelial cells - cells that support the photoreceptors in the eye. The researchers injected around 20,000 engineered stem cells per eye into the retinas of rats. Forty days after treatment the rats were tested for signs of improved vision as compared to a control group that received eye injections without the stem cells. The treated rats were found to be twice as responsive as the control rats in a test that measured retinal electrical activity in response to flashes of light. Other tests showed an improved ability to track movement on a moving display. Microscopic examination after death (at 100 days), showed the treated rats had healthy photoreceptor layers of 5-7 cells thick (unaffected rats have cell layers 10-12 layers thick). The untreated rats had an average thickness of only one cell.

The eye is a particularly desirable region for targeting developing stem cell therapies as it is 'immune-privileged' - 'foreign' cells injected into the eye are not so readily rejected as in other areas of the body. In this experiment all of the injected cells grew normally and did not form tumours or divide in an unusual way. Critics of the experiment, reported in the journal 'Cloning and Stem Cells' point out that the genetically induced eye disorder in the rats is not identical in cause to macular degeneration so any breakthrough may not be applicable to patients with the condition, and also that this treatment can only rescue remaining vision, it cannot restore any photoreceptors which have already degenerated. Any improvement gained by the new technique could also be susceptible to whatever disease process caused the original damage.

Lanza points out that this technique, if successful in humans, would not rely on new embryos or donors. A limited number of stem cell lines could be used to generate a large number of cell lines able to match a good proportion of the population. The company has previously stated its plan to seek permission from the US Food and Drug Administration next year to use stem cells to treat people with macular degeneration. Ian Wilmut, editor of Cloning and Stem Cells and one of the scientists responsible for cloning Dolly the sheep, commented 'These observations are very exciting as they show that one day it will be possible to treat diseases of human eyes with cells', he added that the results, 'emphasize the great potential benefit of research with human embryo stem cells'.

SOURCES & REFERENCES
Human Stem Cells Are Found to Help Rats' Vision
The New York Times |  21 September 2006
Stem cell experiments slow vision loss in rats
The Washington Post |  21 September 2006
Stem cells put a stop to macular degeneration
New Scientist |  21 September 2006
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
11 April 2011 - by Dr Rachael Panizzo 
Embryonic stem cells have been used to generate a basic retina, the part of the eye that detects light and is needed for vision. The retinal tissue could be used to treat some forms of blindness, such as retinitis pigmentosa and age-related macular degeneration, and to investigate and screen potential new drugs for a range of eye diseases....
28 March 2011 - by Dr Sophie Pryor 
US scientists have taken an important step towards using stem cells to treat age-related macular degeneration (AMD), the leading cause of blindness in the UK. The study demonstrates, for the first time, the ability to direct human iPS (induced pluripotent stem) cells to become...
12 November 2006 - by Heidi Nicholl 
In groundbreaking research, scientists have used a new approach to stem cell science to partially restore vision in mice genetically engineered to mimic human degenerative sight defects such as retinitis pigmentosa and macular degeneration. The team, a collaboration between University College London and the University of Michigan...
28 October 2004 - by BioNews 
Two new studies show that cell transplants could be used to treat people with vision problems. US scientists have managed to restore the sight of a woman affected by retinitis pigmentosa, an inherited eye disease. However, the research has sparked controversy, since the team used a sheet of retinal cells...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.